Global Information
회사소개 | 문의 | 비교리스트

컴퓨터단층촬영(CT) 시장 : 유형, 용도, 최종사용자별 - 세계 기회 분석 및 산업 예측(2021-2030년)

Computed Tomography Market by Type, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

리서치사 Allied Market Research
발행일 2021년 12월 상품코드 1059612
페이지 정보 영문 253 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 4,125 ₩ 5,310,000 Excel (Data Pack) help
DRM(디지털 저작권 관리 시스템) 장착 Excel 파일로, 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 Excel파일 라이선스 소유자로 한정됩니다.
US $ 6,168 ₩ 7,940,000 PDF (Single User License + Covid impact) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 6,929 ₩ 8,919,000 PDF (5-user License) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,663 ₩ 13,726,000 PDF (Enterprise User License) help
동일 기업 내의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



컴퓨터단층촬영(CT) 시장 : 유형, 용도, 최종사용자별 - 세계 기회 분석 및 산업 예측(2021-2030년) Computed Tomography Market by Type, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030
발행일 : 2021년 12월 페이지 정보 : 영문 253 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 컴퓨터단층촬영(CT) 시장 규모는 2020년 56억 2,500만 달러에서 예측 기간 중 5.7%의 CAGR로 추이하며, 2030년에는 99억 1,900만 달러 규모로 성장할 것으로 예측됩니다.

세계 컴퓨터단층촬영(CT) 시장의 성장은 주로 고령자 인구의 증가와 전인구에서 만성질환의 증가에 의해 초래됩니다. CT는 각종 종양, 순환(혈액)계 질환, 관상동맥 질환(동맥경화), blood vessel aneurysms, 혈전, 정형외과 질환, 골절, 척추 질환, 신장, 방광결석, 농양, 궤양성 대장염 등의 염증성 질환, 부비강염, 두부, 골격계, 내장 손상의 진단 지원에 널리 사용되고 있습니다.

세계의 컴퓨터단층촬영(CT) 시장을 조사했으며, 시장의 정의와 개요, 시장 영향요인 분석, 시장 규모의 추이·예측, 유형·용도·최종사용자·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 개요

제3장 시장 개요

  • 시장의 정의·범위
  • 주요 조사 결과
  • Porter의 산업 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
    • 영향 분석
  • COVID-19 : 영향 분석

제4장 컴퓨터단층촬영(CT) 시장 : 유형별

  • 개요
  • 로우 슬라이스(64 슬라이스 미만)
  • 미디엄 슬라이스(64 슬라이스)
  • 하이 슬라이스(64 슬라이스 초과)
    • 주요 시장 동향·성장요인·기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제5장 컴퓨터단층촬영(CT) 시장 : 용도별

  • 개요
  • 종양
  • 신경
  • 심혈관
  • 근골격
  • 기타
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 컴퓨터단층촬영(CT) 시장 : 최종사용자별

  • 개요
  • 병원
  • 진단 센터
  • 기타
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제7장 컴퓨터단층촬영(CT) 시장 : 지역별

  • 개요
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카·중동·아프리카
    • 주요 시장 동향·성장요인·기회
    • 컴퓨터단층촬영(CT) 시장 : 유형별
    • 컴퓨터단층촬영(CT) 시장 : 용도별
    • 컴퓨터단층촬영(CT) 시장 : 최종사용자별
    • 시장 규모·예측 : 국가별

제8장 기업 개요 : 컴퓨터단층촬영(CT) 시장

  • CANNON MEDICAL SYSTEMS CORPORATION
  • FUJIFILM HOLDING CORPORATION
  • GE HEALTHCARE
  • KONING CORPORATION
  • KO NINKLIJKE PHILIPS NV
  • NEUROLOGICA CORPORATION
  • NEUSOFT MEDICAL SYSTEMS CO. LTD.
  • SHIMADZU CORPORATION
  • SEIMENS AG
  • STRYKER CORPORATION
KSA 22.03.08

LIST OF TABLES

  • TABLE 01.GLOBAL COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 02.LOW SLICE COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 03.MEDIUM SLICE COMPUTED TOMOGRAPHY MARKET , BY REGION, 2020-2030 ($MILLION)
  • TABLE 04.HIGH SLICE COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 05.GLOBAL COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 06.COMPUTED TOMOGRAPHY MARKET FOR ONCOLOGY BASED, BY REGION, 2020-2030 ($MILLION)
  • TABLE 07.NEUROLOGY COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 08.CARDOVASCULAR COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.MUSCULOSKELETAL COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.OTHER APPLICATIONS COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.GLOBAL COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 12.HOSPITALS COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 13.DIAGNOSTIC CENTERS COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14.OTHER END USERS COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.GLOBAL COMPUTED TOMOGRAPHY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.NORTH AMERICA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 17.NORTH AMERICA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 18.NORTH AMERICA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 19.NORTH AMERICA COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 20.U.S. COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 21.U.S. COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 22.U.S. COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 23.CANADA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 24.CANADA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 25.CANADA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 26.MEXICO COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 27.MEXICO COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 28.MEXICO COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 29.EUROPE COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 30.EUROPE COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 31.EUROPE COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 32.EUROPE COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 33.GERMANY COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 34.GERMANY COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 35.GERMANY COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 36.FRANCE COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 37.FRANCE COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 38.FRANCE COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 39.UK COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 40.UK COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 41.UK COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 42.ITALY COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 43.ITALY COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 44.ITALY COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 45.SPAIN COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 46.SPAIN COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 47.SPAIN COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 48.REST OF EUROPE COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 49.REST OF EUROPE COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 50.REST OF EUROPE COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 51.ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 52.ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 53.ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 54.ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 55.JAPAN COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 56.JAPAN COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 57.JAPAN COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 58.CHINA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 59.CHINA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 60.CHINA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 61.AUSTRALIA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 62.AUSTRALIA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 63.AUSTRALIA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 64.INDIA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 65.INDIA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 66.INDIA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 67.SOUTH KOREA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 68.SOUTH KOREA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 69.SOUTH KOREA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 70.REST OF ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 71.REST OF ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 72.REST OF ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 73.LAMEA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 74.LAMEA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 75.LAMEA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 76.LAMEA COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 77.BRAZIL COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 78.BRAZIL COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 79.BRAZIL COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 80.SAUDI ARABIA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 81.SAUDI ARABIA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 82.SAUDI ARABIA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 83.SOUTH AFRICA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 84.SOUTH AFRICA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 85.SOUTH AFRICA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 86.REST OF LAMEA COMPUTED TOMOGRAPHY MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 87.REST OF LAMEA COMPUTED TOMOGRAPHY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 88.REST OF LAMEA COMPUTED TOMOGRAPHY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 89.CANON: COMPANY SNAPSHOT
  • TABLE 90.CANON: PRODUCT PORTFOLIO
  • TABLE 91.FUJIFILM:COMPANY SNAPSHOT
  • TABLE 92.FUJIFILM: OPERATING SEGMENTS
  • TABLE 93.FUJIFILM: PRODUCT PORTFOLIO
  • TABLE 94.GE:COMPANY SNAPSHOT GE: OPERATING SEGMENTS
  • TABLE 95.GE: PRODUCT PORTFOLIO
  • TABLE 96.KONING: COMPANY SNAPSHOT
  • TABLE 97.KONING : PRODUCT PORTFOLIO
  • TABLE 98.PHILIPS: COMPANY SNAPSHOT
  • TABLE 99.PHILIPS: OPERATING SEGMENTS
  • TABLE 100.PHILIPS: PRODUCT PORTFOLIO
  • TABLE 101.NEUROLOGICA: COMPANY SNAPSHOT
  • TABLE 102.NEUROLOGICA: PRODUCT PORTFOLIO
  • TABLE 103.NEUSOFT : COMPANY SNAPSHOT
  • TABLE 104.NEUSOFT: PRODUCT PORTFOLIO
  • TABLE 105.SHIMADZU: COMPANY SNAPSHOT
  • TABLE 106.SHIMADZU: OPERATING SEGMENTS
  • TABLE 107.SHIMADZU: PRODUCT PORTFOLIO
  • TABLE 108.SIEMENS: COMPANY SNAPSHOT
  • TABLE 109.SIEMENS : OPERATING SEGMENTS
  • TABLE 110.SIEMENS: PRODUCT PORTFOLIO
  • TABLE 111.STRYKER: COMPANY SNAPSHOT
  • TABLE 112.STRYKER : OPERATING SEGMENTS
  • TABLE 113.STRYKER: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.COMPUTED TOMOGRAPHY MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 09.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE COMPETITIVE RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.IMPACT ANALYSIS
  • FIGURE 13.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR LOW SLICE, BY COUNTRY, 2020-2030 (%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR MEDIUM SLICE, BY COUNTRY, 2020-2030 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR HIGH SLICE, BY COUNTRY, 2020-2030 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2030 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR NEUROLOGY, BY COUNTRY, 2020-2030 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR CARDIOVASULAR, BY COUNTRY, 2020-2030 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR MUSCULOSKELETAL, BY COUNTRY, 2020-2030 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 22.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 23.COMPARATIVE ANALYSIS OF COMPUTED TOMOGRAPHY MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 24.CANON: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 25.CANON: REVENUE SHARE BY SEGMENT (%)
  • FIGURE 26.CANON: REVENUE SHARE BY REGION (%)
  • FIGURE 27.FUJIFILM: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 28.FUJIFILM: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 29.FUJIFILM: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 30.GE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 31.GE: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 32.GE: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 33.PHILIPS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 34.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 35.PHILIPS: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 36.SHIMADZU: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 37.SHIMADZU: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 38.SHIMADZU: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 39.SIEMENS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 40.SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 41.SIEMENS: REVENUE SHARE BY REGION, 2020 (%
  • FIGURE 42.STRYKER: NET SALES, 2018-2020 ($MILLION
  • FIGURE 43.STRYKER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 44.STRYKER: REVENUE SHARE BY REGION, 2020 (%)

The global computed tomography market was valued at $5,625.0 million in 2020, and is projected to reach $9,919.0 million by 2030, registering a CAGR of 5.7% from 2021 to 2030. Computed tomography (CT) previously known as computed axial tomography or CT scan, is a noninvasive medical imaging method used in radiology to provide comprehensive pictures of the body for diagnostic reasons. A computed tomography (CT) scan combines a series of X-ray images collected from various angles throughout human body and utilizes computer processing to generate cross-sectional images (slices) of bones and soft tissues. These slices are referred to as tomographic pictures, as they provide more comprehensive information than traditional X-rays.

Traditional X-ray machines employ a fixed tube to direct X-rays to a particular location. CT scans use a doughnut-shaped tube that spins the X-ray around an individual 360 degrees. The information gathered gives a comprehensive 3D picture of the interior of the body. It is used to examine almost all areas of the body, diagnose disease or injury, and plan medical, surgical, or radiation therapy. The cross-sectional images produced by a CT scan can be reformatted in several planes and even produce three-dimensional (3D) images that can be seen on a computer display, printed on film, or transmitted to electronic devices.

CT scan is frequently used as the most effective approach for diagnosing many different types of cancer since the pictures allow doctors to confirm the presence of a tumor as well as its size and location. CT scan is painless and noninvasive process. It can disclose internal injuries and bleeding early enough in an emergency situation to help save lives. It can be used in patients with metallic implants or pacemakers where magnetic resonance imaging (MRI) is contraindicated.

.

The growth of the global computed tomography market is majorly driven by the rise in geriatric population and increase in chronic diseases among the overall population. Thus, surge in incidences of various types of diseases such as cardiovascular, oncology, orthopedic and neurological disorders lead to rise in the usage of CT system that enhances the growth of the market. Computed tomography is widely used to aid in the diagnosis of various tumors, circulatory (blood) system diseases, conditions such as coronary artery disease (atherosclerosis), blood vessel aneurysms, blood clots, orthopedic conditions &fractures, spinal conditions, kidney, bladder stones, abscesses, inflammatory diseases such as ulcerative colitis, sinusitis; and head, skeletal system, &internal organ injuries. According to the Harvard Medical School in 2021, more than 80 million CT scans are performed in the U.S. each year, compared with just 3 million in 1980.

Increase in prevalence of cancer is one of the major reasons for the boost of the computed tomography scans. It shows a tumor's shape, size, &location and even displays the blood vessels that feed the tumor all without having to cut into the patient thus being minimally invasive technique known as CT-guided biopsy. CT scans can be used to guide into tumors during various cancer therapies, such as radiofrequency ablation (RFA), which utilizes heat to kill malignancies. It aids to assess how a tumor responds to treatment or if the cancer has returned after treatment by comparing CT images taken over time.

According to the International Agency for Research on Cancer (IARC), the updated Globocan data of 2020, there were an estimated around 19.3 million cases of cancer. According to World Health Organization (WHO), cancer is a leading cause of death worldwide and approximately 70% of deaths from cancer occur in low& middle income countries. By 2040, the number of new cases of cancer per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to increase to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the growth of computed tomography market.

Cardiovascular diseases (CVDs) are the leading cause of death globally, and it takes an estimated 17.9 million lives each year. According to report of the British Heart Foundation in 2021, 7.6 million people live with heart &circulatory diseases and it causes about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart &blood vessels and it include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. A heart computerized tomography (CT) scan, also called a calcium-score screening heart scan, is used to find calcium deposits in people with heart disease. It is an efficient method of detecting atherosclerosis before symptoms appear. The more coronary calcium, the more coronary atherosclerosis persists, which increases the chances of developing cardiovascular issues in the future. Thus, surge in cardiovascular diseases due to stress, unhealthy lifestyle, and oily food consumptions are expected to drive the computed tomography market.

In addition, technological advancements for development of new products, growth in patient emphasis for early detection of diseases, rise in global prevalence of targeted diseases coupled with an aging population, increased preference for minimally invasive diagnostic procedures and surge in benefits of CT scans over other imaging modalities are factors that are anticipated to drive the growth of the computed tomography market.

On the contrary, the high cost of the implementation of CT scan instruments &their maintenance, compliance with regulatory requirements in developing countries, lack of reimbursement in some countries, and adverse side effects from its radiation can lead to cancer as well, which may hinder the growth of the market.

Emerging markets &significant R&D to develop efficient computed tomography instruments, innovation of various systems, and unmet demand in the under developed &developing countries are projected to provide substantial growth opportunities for key players in computed tomography market.

The computed tomography market is segmented onto the basis of type, application, end user and region. On the basis of type, the market is categorized into low slice, medium slice, and high slice. By application, the market is fragmented into oncology, neurology, cardiovascular, musculoskeletal, and others. By end user, the market is categorized intohospitals & clinic, diagnostic centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global computed tomography market are Cannon Medical Systems Corporation, Fujifilm Holdings Corporation, GE Healthcare, Koning Corporation, Koninklijke Philips NV, Neurologica Corporation, Neusoft Medical Systems CO. Ltd., Shimadzu Corporation, Siemens Healthineers, and Stryker Corporation.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global advanced drug delivery market to identify the prevailing opportunities.
  • This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Region- & country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Product Type

  • Drug eluting lens
  • Microneedle patch
  • Hydrogel drug delivery
  • Nano carrier

By End User

  • Hospitals
  • Specialized clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Alnylam Pharmaceuticals Inc.
  • Altaris Capital Partners Llc. (Kindeva Drug Delivery)
  • Bausch Health Companies Inc., (Bausch & Lomb)
  • Biogen Limited
  • Endo International Plc.
  • Johnson & Johnson (Johnson & Johnson Vision)
  • Micropoint Technologies
  • Novo Nordisk A/S
  • Ocular Therapeutix Inc.
  • Takeda Pharmaceutical Company Limited

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description Key benefits for stakeholders
  • 1.2.Key market segments
    • 1.2.1.List of key players profile in the report
  • 1.3.Research methodology
    • 1.3.1.Secondary research
    • 1.3.2.Primary research
    • 1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Escalating demand for healthcare services from an aging population
      • 3.5.1.2.Rise in prevalence of chronic diseases
      • 3.5.1.3.Greater consumer awareness of and demand for preventive diagnostic screening
      • 3.5.1.4.Utilization of artificial intelligence and augmented reality
      • 3.5.1.5.Technological advancements in computed tomography
    • 3.5.2.Restraint
      • 3.5.2.1.High cost of installation and maintenance
      • 3.5.2.2.Lack of adequate reimbursement and stringent regulatory framework
    • 3.5.3.Opportunity
      • 3.5.3.1.Growth opportunities in emerging markets
    • 3.5.4.Impact analysis
  • 3.6.Impact analysis of COVID-19 on the computed tomography market

CHAPTER 4:COMPUTED TOMOGRAPHY MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Low Slice (<64 Slices)
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Medium Slice (64 Slices)
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.High Slice (>64 Slice)
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country

CHAPTER 5:COMPUTED TOMOGRAPHY MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Oncology
    • 5.2.1.Market size and forecast, by region
    • 5.2.1.Market analysis, by country
  • 5.3.Neurology
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Cardiovascular
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Musculoskeletal
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis, by country
  • 5.6.Others
    • 5.6.1.Market size and forecast, by region
    • 5.6.2.Market analysis, by country

CHAPTER 6:COMPUTED TOMOGRAPHY MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Hospitals
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Diagnostic Centers
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country
  • 6.4.Others
    • 6.4.1.Market size and forecast, by region
    • 6.4.2.Market analysis, by country

CHAPTER 7:COMPUTED TOMOGRAPHY MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.North America Computed tomography market, by type
    • 7.2.3.North America Computed tomography market, by application
    • 7.2.4.North America Computed tomography market, by end user
    • 7.2.5.Market size and forecast, by country
      • 7.2.5.1.U.S.
      • 7.2.5.1.1.U.S. Computed tomography market, by type
      • 7.2.5.1.2.U.S. Computed tomography market, by application
      • 7.2.5.1.3.U.S. Computed tomography market, by end User
      • 7.2.5.2.Canada
      • 7.2.5.2.1.Canada Computed tomography market, by type
      • 7.2.5.2.2.Canada Computed tomography market, by application
      • 7.2.5.2.3.Canada Computed tomography market, by end User
      • 7.2.5.3.Mexico
      • 7.2.5.3.1.Mexico Computed tomography market, by type
      • 7.2.5.3.2.Mexico Computed tomography market, by application
      • 7.2.5.3.3.Mexico Computed tomography market, by end User
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Europe Computed tomography market, by type
    • 7.3.3.Europe Computed tomography market, by Application
    • 7.3.4.Europe Computed tomography market, by End User
    • 7.3.5.Market size and forecast, by country
      • 7.3.5.1.Germany
      • 7.3.5.1.1.Germany Computed tomography market, by type
      • 7.3.5.1.2.Germany Computed tomography market, by application
      • 7.3.5.1.3.Germany Computed tomography market, by end user
      • 7.3.5.2.France
      • 7.3.5.2.1.France Computed tomography market, by Type
      • 7.3.5.2.2.France Computed tomography market, by application
      • 7.3.5.2.3.France Computed tomography market, by End User
      • 7.3.5.3.UK
      • 7.3.5.3.1.UK Computed tomography market, by type
      • 7.3.5.3.2.UK Computed tomography market, by application
      • 7.3.5.3.3.UK Computed tomography market, by end user
      • 7.3.5.4.Italy
      • 7.3.5.4.1.Italy Computed tomography market, by type
      • 7.3.5.4.2.Italy computed tomography market, by application
      • 7.3.5.4.3.Italy Computed tomography market, by end user
      • 7.3.5.5.Spain
      • 7.3.5.5.1.Spain Computed tomography market, by type
      • 7.3.5.5.2.Spain Computed tomography market, by application
      • 7.3.5.5.3.Spain Computed tomography market, by end user
      • 7.3.5.6.Rest of Europe
      • 7.3.5.6.1.Rest of Europe Computed tomography market, by type
      • 7.3.5.6.2.Rest of Europe Computed tomography market, by application
      • 7.3.5.6.3.Rest of Europe Computed tomography market, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Asia-Pacific Computed tomography market, by Type
    • 7.4.3.Asia-Pacific Computed tomography market, by application
    • 7.4.4.Asia-Pacific Computed tomography market, by end user
    • 7.4.5.Market size and forecast, by country
      • 7.4.5.1.Japan
      • 7.4.5.1.1.Japan Computed tomography market, by type
      • 7.4.5.1.2.Japan computed tomography market, by application
      • 7.4.5.1.3.Japan computed tomography market, by end user
      • 7.4.5.2.China
      • 7.4.5.2.1.China computed tomography market, by type
      • 7.4.5.2.2.China computed tomography market, by application
      • 7.4.5.2.3.China computed tomography market, by end user
      • 7.4.5.3.Australia
      • 7.4.5.3.1.Australia computed tomography market, by type
      • 7.4.5.3.2.Australia computed tomography market, by application
      • 7.4.5.3.3.Australia computed tomography market, by end user
      • 7.4.5.4.India
      • 7.4.5.4.1.India computed tomography market, by type
      • 7.4.5.4.2.India computed tomography market, by application
      • 7.4.5.4.3.India computed tomography market, by end user
      • 7.4.5.5.South Korea
      • 7.4.5.5.1.South Korea computed tomography market, by type
      • 7.4.5.5.2.South Korea computed tomography market, by application
      • 7.4.5.5.3.South Korea computed tomography market, by end user
      • 7.4.5.6.Rest of Asia-Pacific
      • 7.4.5.6.1.Rest of Asia-Pacific computed tomography market, by type
      • 7.4.5.6.2.Rest of Asia-Pacific computed tomography market, by application
      • 7.4.5.6.3.Rest of Asia-Pacific computed tomography market, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.LAMEA Computed tomography market, by type
    • 7.5.3.LAMEA Computed tomography market, by application
    • 7.5.4.LAMEA Computed tomography market, by end user
    • 7.5.5.Market size and forecast, by country
      • 7.5.5.1.Brazil
      • 7.5.5.1.1.Brazil computed tomography market, by type
      • 7.5.5.1.2.Brazil computed tomography market, by application
      • 7.5.5.1.3.Brazil computed tomography market, by end user
      • 7.5.5.2.Saudi Arabia
      • 7.5.5.2.1.Saudi Arabia computed tomography market, by type
      • 7.5.5.2.2.Saudi Arabia computed tomography market, by application
      • 7.5.5.2.3.Saudi Arabia computed tomography market, by end user
      • 7.5.5.3.South Africa
      • 7.5.5.3.1.South Africa computed tomography market, by type
      • 7.5.5.3.2.South Africa computed tomography market, by application
      • 7.5.5.3.3.South Africa computed tomography market, by end user
      • 7.5.5.4.Rest of LAMEA
      • 7.5.5.4.1.Rest of LAMEA computed tomography market, by type
      • 7.5.5.4.2.Rest of LAMEA computed tomography market, by application
      • 7.5.5.4.3.Rest of LAMEA computed tomography market, by end user

CHAPTER 8:COMPANY PROFILES: COMPUTED TOMOGRAPHY (CT) MARKET

  • 8.1.CANNON MEDICAL SYSTEMS CORPORATION
    • 8.1.1.Company overview
  • 8.2.FUJIFILM HOLDING CORPORATION
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Business performance
    • 8.2.6.Key strategic moves and developments
  • 8.3.GE HEALTHCARE
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.KONING CORPORATION
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Key strategic moves and developments
  • 8.5.KO NINKLIJKE PHILIPS NV
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
  • 8.5.5Business performance
    • 8.5.6.Key strategic moves and developments
  • 8.6.NEUROLOGICA CORPORATION
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Product portfolio
    • 8.6.4.Key strategic moves and developments
  • 8.7.NEUSOFT MEDICAL SYSTEMS CO. LTD.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Product portfolio
    • 8.7.4.Key strategic moves and developments
  • 8.8.SHIMADZU CORPORATION
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.SEIMENS AG
  • 8.9.1Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product Portfolio
    • 8.9.5.Business performance
    • 8.9.6.Key strategic moves and developments
  • 8.10.STRYKER CORPORATION
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product Portfolio
    • 8.10.5.Business performance
Back to Top
전화 문의
F A Q